MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection
MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection
ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer
Disparities in mammogram screening amongst LGBTQ+ populations
AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers
Social determinants and survival outcomes in early-onset colorectal cancer in the US
Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform
Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy
ASCO 2025: Update on blood-based cancer assays
Transperineal biopsy improves prostate cancer detection
Boost IORT in breast cancer: Peruvian experience
Intraoperative radiotherapy for brain tumours
ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib